CanSino’s COVID-19 Vaccine Was Just Approved for Limited Use in China. Here’s What Investors Should Know.

Despite a worldwide race to develop a COVID-19 vaccine, China’s CanSino Biologics didn’t make huge headlines when it announced last week that its COVID-19 vaccine candidate had be …
( read original story …)